The postantifungal and paradoxical effects of echinocandins against Candida spp.

Future Microbiology

Volumn 7, Issue 5, 2012, Pages 565-569

  Moriyama, Brad ^a   Henning, Stacey A ^a   Penzak, Scott R ^a   Walsh, Thomas J ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Department of Molecular Biology and Genetics   (United States)

Author keywords

Candida spp; echinocandin; paradoxical effect; postantifungal effect

Indexed keywords

CASPOFUNGIN;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DRUG EXPOSURE; DRUG SCREENING; FUNGUS GROWTH; FUNGUS ISOLATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; ECHINOCANDINS;

CANDIDA; CANDIDA ALBICANS;

EID: 84860855980     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.31     Document Type: Article

References (25)

1. Denning DW. Echinocandin antifungal drugs. Lancet 362(9390), 1142-1151 (2003). (Pubitemid 37222342)
2. Cappelletty D, Eiselstein-McKitrick K. The echinocandins. Pharmacotherapy 27(3), 369-388 (2007). (Pubitemid 46327905)
3. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48(5), 503-535 (2009).
4. Petraitis V, Petraitiene R, Groll AH et al. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. Antimicrob. Agents Chemother. 45(2), 471-479 (2001). (Pubitemid 32105283)
5. Ernst EJ, Klepser ME, Pfaller MA. Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrob. Agents Chemother. 44(4), 1108-1111 (2000). (Pubitemid 30165304)
6. Stevens DA, Espiritu M, Parmar R. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother. 48(9), 3407-3411 (2004). (Pubitemid 39129338)
7. Manavathu EK, Ramesh MS, Baskaran I, Ganesan LT, Chandrasekar PH. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans. J. Antimicrob. Chemother. 53(2), 386-389 (2004). (Pubitemid 38239980)
8. Clancy CJ, Huang H, Cheng S, Derendorf H, Nguyen MH. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob. Agents Chemother. 50(7), 2569-2572 (2006). (Pubitemid 43993208)
9. Ernst EJ, Roling EE, Petzold CR, Keele DJ, Klepser ME. In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies. Antimicrob. Agents Chemother. 46(12), 3846-3853 (2002). (Pubitemid 35403260)
10. Nguyen KT, Ta P, Hoang BT et al. Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates. Antimicrob. Agents Chemother. 53(8), 3347-3352 (2009).
11. Smith RP, Baltch A, Bopp LH, Ritz WJ, Michelsen PP. Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis. Diagn. Microbiol. Infect. Dis. 71(2), 131-138 (2011).
12. Di Bonaventura G, Spedicato I, Picciani C, D'Antonio D, Piccolomini R. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies. Antimicrob. Agents Chemother. 48(11), 4453-4456 (2004). (Pubitemid 39434915)
13. Stevens DA, White TC, Perlin DS, Selitrennikoff CP. Studies of the paradoxical effect of caspofungin at high drug concentrations. Diagn. Microbiol. Infect. Dis. 51(3), 173-178 (2005). (Pubitemid 40568760)
14. Chamilos G, Lewis RE, Albert N, Kontoyiannis DP. Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin- specific and Candida species-related differences. Antimicrob. Agents Chemother. 51(6), 2257-2259 (2007). (Pubitemid 46903132)
15. Clemons KV, Espiritu M, Parmar R, Stevens DA. Assessment of the paradoxical effect of caspofungin in therapy of candidiasis. Antimicrob. Agents Chemother. 50(4), 1293-1297 (2006).
16. Bayegan S, Majoros L, Kardos G et al. In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin. J. Microbiol. 48(2), 170-173 (2010).
17. Stevens DA, Ichinomiya M, Koshi Y, Horiuchi H. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for b-1,6-glucan synthesis inhibition by caspofungin. Antimicrob. Agents Chemother. 50(9), 3160-3161 (2006). (Pubitemid 44396427)
18. Bizerra FC, Melo AS, Katchburian E et al. Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species. Antimicrob. Agents Chemother. 55(1), 302-310 (2011).
19. Wiederhold NP, Kontoyiannis DP, Prince RA, Lewis RE. Attenuation of the activity of caspofungin at high concentrations against Candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob. Agents Chemother. 49(12), 5146-5148 (2005). (Pubitemid 41778937)
20. Shields RK, Nguyen MH, Du C, Press E, Cheng S, Clancy CJ. Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum. Antimicrob. Agents Chemother. 55(6), 2641-2647 (2011).
21. Kaneko Y, Ohno H, Imamura Y, Kohno S, Miyazaki Y. The effects of an hsp90 inhibitor on the paradoxical effect. Jap. J. Infect. Dis. 62(5), 392-393 (2009).
22. Shields RK, Nguyen MH, Press EG, Clancy CJ. Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicans. Antimicrob. Agents Chemother. 55(7), 3598-3602 (2011).
23. Katragkou A, Chatzimoschou A, Simitsopoulou M et al. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob. Agents Chemother. 52(1), 357-360 (2008).
24. Melo AS, Colombo AL, Arthington-Skaggs BA. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob. Agents Chemother. 51(9), 3081-3088 (2007). (Pubitemid 350067512)
25. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, López-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46(11), 3634-3636 (2002). (Pubitemid 35192940)